Ahmet ARNAZ, Ayla OKTAY, Serdar AKANSEL, Dilek ALTUN, Abdullah DOĞAN, Piotr SERBAN, Arda SAYGILI, Yusuf YALÇINBAŞ, Ayşe SARIOĞLU, Tayyar SARIOĞLU

Pulmonary valve replacement in patients with repaired tetralogy of Fallot: early results for recovery of right ventricular dilatation and QRS duration

Background/aim: Although pulmonary valve replacement (PVR) improves ventricular function and symptoms, the benefit and optimal timing of PVR are controversial. This study aimed to evaluate early response to PVR for right ventricle (RV) dilatation and QRS duration. Materials and methods: Retrospective analysis was performed for 32 patients with repaired tetralogy of Fallot (TOF) between March 2005 and October 2017. The differences between preoperative and postoperative changes in echocardiographic parameters, clinical symptoms, and QRS duration were evaluated. Results: There were no in-hospital or late deaths. Mean age at the time of PVR was 16.57 ± 7.97 years. The interval between TOF repair and PVR was 12.99 ± 7.06 years. Postoperative echocardiographic findings showed significant reduction in indexed RV end-diastolic diameter (RV-EDDI) and the ratio of RV/LV-EDDI (P = 0.001 and P = 0.001, respectively). Higher preoperative RV-EDDI was associated with decreased change in RV-EDDI after PVR (r = 0.63; P = 0.001). Normalization of RV diameters was found to be independent of age at PVR, interval between TOF repair and PVR, preoperative QRS duration, and preoperative RV-EDDI. Conclusion: Significant improvement in RV diameter and symptoms could be obtained with PVR in patients with severe pulmonary regurgitation.

Keywords:

Tetralogy of Fallot, pulmonary regurgitation, pulmonary valve replacement, ventricular remodeling, QRS duration,

PDF

___

Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001; 37: 1170-1175.
Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 2009; 119: 1370-1377.
Cheung EWY, Wong WHS, Cheung YF. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol 2010; 106: 552-557.
Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, Nido PD. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation 2010; 122: S201-S208.
Baumgartner H, Bonhoeffer P, De Groot NMS, De Haan F, Deanfield JE, Galie N, Gatzoulis MA, Baerwolf CG, Kaemmerer H, Kilner P et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-2957.
Ferraz Cavalcanti PE, Sá MP, Santos CA, Esmeraldo IM, de Escobar RR, de Menezes AM, de Azevedo OM Jr, de Vasconcelos Silva FP, Lins RF, Lima Rde C. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta- analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol 2013; 62: 2227-2243.
Koestenberger M, Nagel B, Ravekes W, Avian A, Burmas A, Grangl G, Cvirn G, Gamillscheg A. Reference values and calculation of z-scores of echocardiographic measurements of the normal pediatric right ventricle. Am J Cardiol 2014; 114: 1590-1598.
Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004; 43: 1068-1074.
Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26: 433-439.
Lee C, Kim YM, Lee CH, Kwak JG, Park CS, Song JY, Shim WS, Choi EY, Lee SY, Baek JS. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012; 60: 1005-1014.
Li W, Davlouros PA, Kilner PJ, Pennell DJ, Gibson D, Henein MY, Gatzoulis MA. Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. Am Heart J 2004; 147: 165-172.
Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh EP. Pulmonary valve replacement in tetralogy of Fallot. Impact on survival and ventricular tachycardia. Circulation 2009; 119: 445-451.
Gengsakul A, Harris L, Bradley TJ, Webb GD, Williams WG, Siu SC, Merchant N, McCrindle BW. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardio-Thoracic Surg 2007; 32: 462-468.
Lee C, Park CS, Lee CH, Kwak JG, Kim SJ, Shim WS, Song JY, Choi EY, Lee SY. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011; 142: 351-358.
Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011; 13: 9.
Frigiola A, Tsang V, Nordmeyer J, Lurz P, van Doorn C, Taylor AM, Bonhoeffer P, de Leval M. Current approaches to pulmonary regurgitation. Eur J Cardio-Thoracic Surg 2008; 34: 576-581.
Frigiola A, Tsang V, Bull C, Coats L, Khambadkone S, Derrick G, Mist B, Walker F, Doorn CV, Bonhoeffer P et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 2008; 118: 182-191.
Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005; 95: 779-782.
Valsangiacomo Buechel ER, Dave HH, Kellenberger CJ, Dodge- Khatami A, Pretre R, Berger F, Bauersfeld U. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J 2005; 26: 2721-2727.
Chalard A, Sanchez I, Gouton M, Henaine R, Salami FA, Ninet J, Douek PC, Filippo SD, Boussel L. Effect of pulmonary valve replacement on left ventricular function in patients with tetralogy of Fallot. Am J Cardiol 2012; 110: 1828-1835.
Jang W, Kim YJ, Choi K, Lim HG, Kim WH, Lee JR. Mid- term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardio-Thoracic Surg 2012; 42: 1-8.
Shiokawa Y, Sonoda H, Tanoue Y, Nishida T, Nakashima A, Tominaga R. Pulmonary valve replacement long after repair of tetralogy of Fallot. Gen Thorac Cardiovasc Surg 2012; 60: 341- 344.
Oosterhof T, Van Straten A, Vliegen HW, Meijboom FJ, Van Dijk APJ, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116: 545-551.